Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

Fabio A.B. Schutz, Denis L.F. Jardim, Youjin Je, Toni K. Choueiri, Haematologic toxicities associated with the addition of bevacizumab in cancer patients European Journal of Cancer. ,vol. 47, pp. 1161- 1174 ,(2011) , 10.1016/J.EJCA.2011.03.005

H Elnakat, Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy ☆ Advanced Drug Delivery Reviews. ,vol. 56, pp. 1067- 1084 ,(2004) , 10.1016/J.ADDR.2004.01.001

E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer. ,vol. 45, pp. 228- 247 ,(2009) , 10.1016/J.EJCA.2008.10.026

Ignace B. Vergote, Christian Marth, Robert L. Coleman, Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications Cancer and Metastasis Reviews. ,vol. 34, pp. 41- 52 ,(2015) , 10.1007/S10555-014-9539-8

Alison Davis, Anna V. Tinker, Michael Friedlander, “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit? Gynecologic Oncology. ,vol. 133, pp. 624- 631 ,(2014) , 10.1016/J.YGYNO.2014.02.038

Olga Ab, Kathleen R. Whiteman, Laura M. Bartle, Xiuxia Sun, Rajeeva Singh, Daniel Tavares, Alyssa LaBelle, Gillian Payne, Robert J. Lutz, Jan Pinkas, Victor S. Goldmacher, Thomas Chittenden, John M. Lambert, IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors Molecular Cancer Therapeutics. ,vol. 14, pp. 1605- 1613 ,(2015) , 10.1158/1535-7163.MCT-14-1095

Claudia Marchetti, Margherita Giorgini, Caterina De Medici, Innocenza Palaia, Roberta Iadarola, Laura Vertechy, Ludovico Muzii, Pierluigi Benedetti Panici, Lavinia Domenici, Violante Di Donato, Federica Tomao, Targeted drug delivery via folate receptors in recurrent ovarian cancer: A review OncoTargets and Therapy. ,vol. 7, pp. 1223- 1236 ,(2014) , 10.2147/OTT.S40947

Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Tjoung-Won Park-Simon, Gordon Rustin, Florence Joly, Mansoor R Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh K B Parmar, Timothy J Perren, Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial The Lancet Oncology. ,vol. 16, pp. 928- 936 ,(2015) , 10.1016/S1470-2045(15)00086-8

Mary Ann Jordan, Emin Oroudjev, Manu Lopus, Leslie Wilson, Charlene Audette, Carmela Provenzano, Hans Erickson, Yelena Kovtun, Ravi Chari, Maytansinoid-Antibody Conjugates Induce Mitotic Arrest by Suppressing Microtubule Dynamic Instability Molecular Cancer Therapeutics. ,vol. 9, pp. 2700- 2713 ,(2010) , 10.1158/1535-7163.MCT-10-0645

Jonathan A. Ledermann, Christian Marth, Mark S. Carey, Michael Birrer, David D.L. Bowtell, Stan Kaye, Iain McNeish, Amit Oza, Giovanni Scambia, Gordon Rustin, Frederick B. Stehman, David Gershenson, Gillian Thomas, Els Berns, Antonio Casado, Nelleke Ottevanger, Felix Hilpert, Byoung-Gie Kim, Aikou Okamoto, Monica Bacon, Henry Kitchener, Gavin C.E. Stuart, Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer International Journal of Gynecological Cancer. ,vol. 21, pp. 763- 770 ,(2011) , 10.1097/IGC.0B013E31821B2669